SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-035954
Filing Date
2024-08-06
Accepted
2024-08-06 17:28:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA 14A ny20030749x5_defa14a.htm DEFA14A 23662
  Complete submission text file 0001140361-24-035954.txt   24747
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37465 | Film No.: 241180638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)